William C Bertrand Jr bought ADAP once, on Dec 14, 2020

William (Bill) Bertrand, Jr., J.D. is an individual corporate executive and board director with a long career in biotechnology and pharmaceuticals.( He served as Chief Operating Officer of Adaptimmune Therapeutics plc from March 2017, where he led operational functions including business operations, legal/IP, compliance, human resources, quality, corporate affairs, and IT, and also served as Chief Compliance Officer.( Adaptimmune announced in November 2025 that Bertrand had left the company as part of a restructuring, indicating that he is no longer serving in that role.(

Before Adaptimmune, Bertrand was executive vice president and general counsel at Infinity Pharmaceuticals, held senior leadership roles at Salix Pharmaceuticals including acting chief operating officer and general manager, and spent 12 years at MedImmune in positions of increasing responsibility, including executive vice president and general counsel.( He also serves on the board of Ardelyx and has board experience with other organizations; he earned a B.S. in Biology from Wayne State University and a J.D. from the University of Wisconsin–Madison.(

Written by Perplexity from public sources.